Literature DB >> 21088474

Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients.

E Cakir1, M Ozbek, E Ozkaya, N Colak, E Cakal, M Sayki, A Gungunes, Y Aliyazicioglu, A Mentese, T Delibasi.   

Abstract

BACKGROUND: Early atherosclerosis and increased risk of cardiovascular diseases (CVD) have been reported in patients with polycystic ovary syndrome (PCOS). Oxidative stress is an accepted risk factor for the development of CVD. AIM: To evaluate the association between oxidative stress markers [ischemia-modified albumin (IMA), total antioxidant status (TAS), and total oxidant status (TOS) levels], carotid intima- media thickness (CIMT), endocrine and metabolic parameters in patients with PCOS. MATERIALS, SUBJECTS, AND METHODS: We studied 52 patients with PCOS and 36 age- and body mass index (BMI)-matched controls. The diagnosis of PCOS was made according to the Rotterdam criteria. Metabolic, hormonal parameter and IMA, TAS, TOS levels were measured.
RESULTS: No statistically significant difference was determined in relation to age, BMI and waist-hip ratio, IMA, TAS, and TOS levels between groups. Mean IMA level was higher in PCOS patients, however, statistical significant difference was not observed. Mean CIMT and homeostasis model assessment of insulin resistance levels were significantly higher in patients with PCOS than in control subjects.
CONCLUSION: Our study has shown that although CIMT levels, showing CVD risk, were higher in PCOS patients, TAS and TOS oxidative stress markers were found to be similar between groups, IMA was higher in PCOS patients however the difference was not reach statistical significant. The present results suggest that CIMT increases before the state of ischemia and shows preischemic state of vasculature, while oxidative stress markers are considered to be indicators of ischemia and reperfusion injury in progressive vascular disease. Further studies are needed to show the association between oxidative stress markers, CVD and PCOS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088474     DOI: 10.3275/7352

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  41 in total

1.  Plasma protein oxidation and antioxidant defense during aging.

Authors:  S Garibaldi; S Valentini; I Aragno; M A Pronzato; N Traverso; P Odetti
Journal:  Int J Vitam Nutr Res       Date:  2001-11       Impact factor: 1.784

Review 2.  Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Authors:  H Robert Superko; Radhika R Gadesam
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

3.  Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.

Authors:  C Meyer; B P McGrath; H J Teede
Journal:  J Clin Endocrinol Metab       Date:  2005-07-26       Impact factor: 5.958

4.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

5.  Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

Authors:  D S Guzick; E O Talbott; K Sutton-Tyrrell; H C Herzog; L H Kuller; S K Wolfson
Journal:  Am J Obstet Gynecol       Date:  1996-04       Impact factor: 8.661

6.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report.

Authors:  D Bar-Or; E Lau; J V Winkler
Journal:  J Emerg Med       Date:  2000-11       Impact factor: 1.484

7.  Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease.

Authors:  Veysel Fenkci; Semin Fenkci; Mehmet Yilmazer; Mustafa Serteser
Journal:  Fertil Steril       Date:  2003-07       Impact factor: 7.329

8.  Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries.

Authors:  Kalpana Lakhani; Paul Hardiman; Alexander M Seifalian
Journal:  Atherosclerosis       Date:  2004-08       Impact factor: 5.162

Review 9.  Oxidative stress and cardiovascular disease: novel tools give (free) radical insight.

Authors:  Ian M Fearon; Stephen P Faux
Journal:  J Mol Cell Cardiol       Date:  2009-05-28       Impact factor: 5.000

10.  The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.

Authors:  Francesco Orio; Stefano Palomba; Letizia Spinelli; Teresa Cascella; Libuse Tauchmanovà; Fulvio Zullo; Gaetano Lombardi; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  3 in total

Review 1.  Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

Authors:  Krystallenia I Alexandraki; Eleni A Kandaraki; Kalliopi-Anna Poulia; Christina Piperi; Eirini Papadimitriou; Theodoros G Papaioannou
Journal:  touchREV Endocrinol       Date:  2021-04-28

2.  The Total Antioxidant Status, Serum Selenium Concentrations and the Ultrasound Assessment Carotid Intima Media Thickness in Patients with Arterial Hypertension.

Authors:  Paweł Gać; Małgorzata Poręba; Lidia Januszewska; Adam Prokopowicz; Helena Martynowicz; Grzegorz Mazur; Rafał Poręba
Journal:  Antioxidants (Basel)       Date:  2021-01-06

3.  Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values.

Authors:  Justyna Niepsuj; Grzegorz Franik; Paweł Madej; Agnieszka Piwowar; Anna Bizoń
Journal:  Biomedicines       Date:  2022-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.